Biotechnology, Healthcare, and Innovation by Bio-Techne

  • Dan Blystone
  • 04.06.2026
Bio-Techne stock rebounds 2.17% as Bio-Techne announces integrated antibody workflow with Refeyn
Bio-Techne announced it has worked with Refeyn to deliver a first-of-its-kind integrated workflow for characterizing charge and size variants in bispecific antibodies and biosimilars.Bio-Techne ...
  • Yaroslav Dmytrenko
  • 29.03.2026
SPYRE Focus Panel launch fails to lift Bio-Techne stock amid pronounced bearish momentum
Bio-Techne is advancing its spatial biology capabilities on the COMET platform with the introduction of new SPYRE Focus Panels and SPYRE Amplification Kits.The company says these additions deliver ...